Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · BROOKS LAB LIMITED · 6 November 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
BROOKS LAB LIMITED NSE: BROOKS · BSE: 533543
BROOKS LAB LIMITED
StateQ1 FY27 filed
Last close · 6 Nov 2026₹63.05
Market cap₹0.2k cr
TTM P/E · P/B · EV/EBITDA14.0 · 1.51 · 32.2
BROOKS LAB LIMITED is a listed company listed on NSE. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
₹ crore · consolidated
FY22
FY23
FY24
FY25
FY26
Revenue
91
63
79
83
86
EBITDA (ex other income)
(14)
(27)
3
5
7
margin %
(15.8)
(42.4)
4.0
6.0
8.2
Owners' profit
(16)
(21)
(20)
(10)
25
EPS, as reported (₹)
(7.82)
(12.57)
(7.67)
(3.72)
8.35
ROE % · ROCE %
(14.4) · (14.1)
(43.0) · (43.9)
(29.9) · 3.6
(10.2) · 4.2
20.0 · 5.3
Debt / equity (x)
0.18
0.08
0.08
0.06
0.06
Cash from operations
(37)
(14)
(10)
3
9
Capex
(28)
(0)
(0)
(1)
(4)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · BROOKS LAB LIMITED · 6 November 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 8 quarters
₹ crore
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Q2 FY26
Q3 FY26
Q4 FY26
Q1 FY27
Revenue
21
21
23
26
23
17
20
23
Profit before tax
1
1
2
3
2
0
1
1
Net profit
(4)
(2)
(1)
10
8
5
2
(2)
EPS (₹)
(1.51)
(0.82)
(0.54)
3.25
2.71
1.87
0.52
(0.61)
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Exhibit 3: Segment revenue, FY26
Segment
Revenue, ₹ crore
Share %
a) Trading
0
0.4
b) Manufacturing
20
33.2
TRADING
2
3.8
MANUFACTURING
38
62.7
Total, before eliminations
60
100.0
Source: the filed segment block, four quarters summed.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · BROOKS LAB LIMITED · 6 November 2026Page 3 of 3
Exhibit 4: Filings of the last 90 days, with the measured price reaction
Date · filing
Category
Importance
Next day %
5-day %
3 Nov 2026 · Board to approve September quarter and half-year results on November 7
results
low
—
—
3 Nov 2026 · Board meeting set to approve September 2026 financial results
results
low
—
—
14 Oct 2026 · Brooks Lab board approves demerger of Manufacturing Business into Abridge
strategic transactions
medium
—
—
14 Oct 2026 · Brooks Labs board approves 1:1 demerger of Manufacturing Business into Abridge
strategic transactions
high
—
—
13 Oct 2026 · Brooks Labs says no undisclosed info behind price movement
regulatory legal
medium
—
—
12 Oct 2026 · BSE seeks clarification from Brooks Lab on price movement
regulatory legal
high
—
—
9 Oct 2026 · Routine compliance filing under Regulation 74(5) for Q2 FY26
16 Sept 2026 · Company Secretary and Compliance Officer resigns effective 9 October 2026
management changes
medium
—
—
16 Sept 2026 · Newspaper notice for re-lodgement of physical share transfers
compliance
minimal
—
—
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).
How to read this document
Where a broker report shows
This document shows
Why
A rating (BUY / ADD / REDUCE / SELL)
A state: the latest filed quarter and the measured reactions
an event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upside
The current price and the multiples against the group
a target is a forecast; a multiple is a measurement
Estimate years marked E
More audited years; no estimates
MarketPing publishes no forecasts — your own model lives on the Models page
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
